Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Blinder

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Hematology|April 1, 1996
Multimodality therapy of an acquired factor V inhibitorY X Fu, R Kaufman, A E Rudolph, et al.
Clinical Chemistry|April 29, 1998
Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populationsA E Mast, M A Blinder, A M Gronowski, et al.
Biochemistry|January 26, 1988
Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coliM A Blinder, J C Marasa, C H Reynolds, et al.
Biochemistry|February 5, 1991
Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11R Herzog, S Lutz, N Blin, et al.
Biochemistry|October 28, 1998
Allosteric effects of a monoclonal antibody against thrombin exosite IIN S Colwell, M A Blinder, M Tsiang, et al.
American Journal of Hematology|May 9, 2001
Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphismsA R Tabrizi, S D McGrath, M A Blinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Hematology|April 1, 1996
Multimodality therapy of an acquired factor V inhibitorY X Fu, R Kaufman, A E Rudolph, et al.
Clinical Chemistry|April 29, 1998
Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populationsA E Mast, M A Blinder, A M Gronowski, et al.
Biochemistry|January 26, 1988
Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coliM A Blinder, J C Marasa, C H Reynolds, et al.
Biochemistry|February 5, 1991
Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11R Herzog, S Lutz, N Blin, et al.
Biochemistry|October 28, 1998
Allosteric effects of a monoclonal antibody against thrombin exosite IIN S Colwell, M A Blinder, M Tsiang, et al.
American Journal of Hematology|May 9, 2001
Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphismsA R Tabrizi, S D McGrath, M A Blinder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Pageof 2